Abstract B cell maturation antigen (BCMA) is an ideal target for precise treatment due to its highly selective expression on malignant myeloma cells. This review summarizes briefly the advances in the latest research progress on biological activity of BCMA, its significance as a biomarker and immunotherapy direcited against BCMA, such as bispecific antibodies, antibody drug conjugates, chimeric antigen receptor T cell therapy against mature B cell antigens.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.19746/j.cnki.issn.1009-2137.2019.05.053 | DOI Listing |
Publication Analysis
Top Keywords
[advance immunotherapy
4
immunotherapy targeting
4
cell
4
targeting cell
4
cell maration
4
maration antigen
4
antigen multiple
4
multiple myeloma--review]
4
myeloma--review] abstract b
4
abstract b cell
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!